openPR Logo
Press release

Global Cell & Gene Therapy Raw Material Testing Market | Key players are Merck KGaA, Catalent Inc., Charles River, Agilent Technologies, Pace Analytical Life Sciences, Element Material Technology, Intertek Group PLC, and Eurofins Scientific.

07-14-2022 03:33 PM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd.

Global Cell & Gene Therapy Raw Material Testing Market | Key

The Global Cell & Gene Therapy Raw Material Testing Market is estimated to reach over USD 59.04 billion by 2030, exhibiting a CAGR of 19.18% during the forecast period.

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1327

The market has been primarily driven by an exponential increase in the clinical pipeline and the number of regulatory approvals for innovative medicines. Participants in the market are concentrating their efforts on increasing their market presence in light of the attractive growth possibilities in the contract development of cellular and gene-modified medicines.

Additionally, to speed up the R&D of their candidate programs, bio manufacturers are forming strategic collaborations with contract manufacturers. Increased demand for CMO/CDMO services has prompted the entry of a number of new competitors and the increase of product development capacities, both of which have a favourable effect on market revenue. In order to enhance the production of cell and gene therapies, several innovative techniques are being introduced. For instance, the makers are investigating the potential of single-use technology in manufacturing workflows. This method is becoming more popular in this field since it may expedite development while also cutting costs and production times. In the upcoming years, market growth is predicted to be supported by such technical products in space.

List of Prominent Players in the Cell & Gene Therapy Raw Material Testing Market:
Thermo Fisher Scientific
Merck KGaA
Catalent Inc.,
Charles River
Pace Analytical Life Sciences
Agilent Technologies
Intertek Group PLC
Element Material Technology
Eurofins Scientific
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/report/global-cell--gene-therapy-raw-material-testing-market/1327

Market Dynamics:
Drivers-
The high frequency of cancer and other target diseases, the accessibility of reimbursements, and the rising financing for gene therapy research all contribute to the market's expansion. The biopharmaceutical business has seen tremendous change as a result of the commercialization of highly sophisticated treatments, which has also altered how many severe and uncommon ailments are treated. The increasing rise of the advanced treatment background is one factor fueling the market expansion for cell and gene therapy manufacturing. For cellular products and gene-modified medicines, the healthcare sector has observed an ideal ratio of clinical success to the number of clinical studies during the previous few years. This is due to the advancements in clinical and technical understanding of the security hazards associated with the use of these products.

Challenges:
The development of the global cell and gene therapy raw material testing market may be constrained in the following years due to the high cost of bioassay services. Despite product development and technological advancement over the past ten years, the market has been hampered by a dearth of skilled workers who can operate sophisticated devices like flow cytometers and multi-mode readers. Modern, very complicated flow cytometers and spectrophotometers produce a variety of data outputs that call for specialized interpretation and analysis. Therefore, there is a global shortage of competent workers.

Regional Trends:
During the forecast period, the North American region is anticipated to account for the highest share of the global market for evaluating raw materials for cell and gene therapy. The North American area will rule the global market for evaluating raw materials for cell and gene therapies due to a growth in healthcare-related research. A few factors that influence the market in the United States include an improvement in the standard of life and new innovations in the medical field. The United States is a centre for complicated medical treatments for many individuals worldwide because it is one of the world's most developed countries. For instance, a large number of allogeneic transplant recipients are housed in a research facility in the United States. With the improved facilities and a wide range of treatments, the cell and gene therapy raw material testing market in the US has been vital.

Recent Developments:
• In November 2021, WuXi Advanced Therapies (US) opened a 140,000-square-foot cell and gene therapy testing centre. By tripling the company's prior testing capacity, this facility will further strengthen the contract testing, development, and manufacturing organization (CTDMO) business model and fulfil the growing demands of clients in the cell and gene therapy industries.

• In April 2021, PPD, Inc., a multinational contract research organization (CRO), is enlarging its GMP laboratory in Athlone, Ireland, increasing the size of its current facility, and extending the operation's range of services to include cell and gene therapy testing. With the growth, PPD will be better able to fulfil the increasing demand from clients in Europe, the Middle East and Africa, and the Asia-Pacific area for worldwide scientific and technical knowledge.

Segmentation of Cell & Gene Therapy Raw Material Testing Market -
By Service
• Sterility Testing
• Mycoplasma Detection Assays
• Endotoxin Detection
• Bioburden Testing
• Others

By Type
• Cell Therapy
• Gene Therapy

By Region-
North America-
• The US
• Canada
• Mexico

Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America-
• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Information @ https://www.insightaceanalytic.com/report/global-cell--gene-therapy-raw-material-testing-market/1327

InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cell & Gene Therapy Raw Material Testing Market | Key players are Merck KGaA, Catalent Inc., Charles River, Agilent Technologies, Pace Analytical Life Sciences, Element Material Technology, Intertek Group PLC, and Eurofins Scientific. here

News-ID: 2680265 • Views:

More Releases from InsightAce Analytic Pvt. Ltd.

Veterinary Antimicrobial Susceptibility Testing : Current Scenario, Regional Outlook, Market Size, Share, Major Players, Challenges and Segmentations, Report Forecast to 2031
Veterinary Antimicrobial Susceptibility Testing : Current Scenario, Regional Out …
The global veterinary antimicrobial susceptibility testing market is estimated to be worth 111.83 million in 2023 and will grow to 181.37 million by 2031, with a compound annual growth rate (CAGR) of 6.31% during the forecast period of 2024-2031. Download Free Sample Pages @ https://www.insightaceanalytic.com/request-sample/1686 The market's expansion is driven by the increasing prevalence of multidrug-resistant organisms and the growing interest in precision medicine. Antibiotic-resistant infections in the United States annually exceed
Veterinary Antibiotics : Market Insight , Size Share, Massive CAGR Development And Business Strategies, Challenges & Segmentations, Regional Outlook and Major Companies Forecast by 2031
Veterinary Antibiotics : Market Insight , Size Share, Massive CAGR Development A …
The market size of veterinary antibiotics is estimated to be USD 4898.48 million in 2023 and is expected to increase to USD 6316.37 million by 2031, with a compound annual growth rate (CAGR) of 3.34 percent for the forecast period of 2024-2031. Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1128 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global veterinary antibiotics market are: • Increase in animal health issues • Rising popularity of pet insurance • Rising awareness
Vegan Cosmetics : Size, Share, Market Growth, Types, Regions and Applications Research Report , Latest Drivers, Prominent Players, Analysis & Challenges , Forecast to 2031
Vegan Cosmetics : Size, Share, Market Growth, Types, Regions and Applications Re …
During the forecast period of 2024-2031, the Global Vegan Cosmetics Market Size is expected to increase from USD 17.80 billion in 2023 to USD 32.48 billion by 2031, with a compound annual growth rate (CAGR) of 8.06%. Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1495 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the vegan cosmetics market are: • Growing environmental awareness • Rising consumer disposable income • Growing Interest in Plant-Based Goods Future expansion opportunities for the vegan cosmetics
Fructooligosaccharide Market expected to Witness Huge Revenue Growth to 2031
Fructooligosaccharide Market expected to Witness Huge Revenue Growth to 2031
Fructooligosaccharide Market Size, Share & Trends Analysis Report By Source (Sucrose, Insulin), By Form (Solid, Liquid), By Application (Infant Formulations, Food & beverages, Animal feed, Dietary supplements, Pharmaceuticals), By Region, And by Segment Forecasts, 2024-2031. The Fructooligosaccharide Market Size is valued at USD 3.01 Billion in 2023 and is predicted to reach USD 7.55 Billion by the year 2031 at a 12.29 % CAGR during the forecast period for 2024-2031. Get A

All 5 Releases


More Releases for Therapy

Global Corticosteroids Therapy Market | Global Corticosteroids Therapy Industry …
The corticosteroids therapy market comprises of sales of artificial corticosteroid drugs utilized to treat a wide variety of syndromes, including asthma, arthritis, skin conditions, and autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives vary in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are active at physiological doses for additional therapy when endogenous manufacture is impaired. The market involves of revenue created
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Global Biologic Therapy Market up to 2023 | Staggering Double Digit CAGR By Ther …
Market Research Future published a research report on Global Biologic Therapy Market and predicts that Global General Surgical Devices Market is expected to grow at a healthy CAGR of 6.1% during the forecasted period and report include market Analysis, Size, Share, Recent Trends and forecast till 2023. The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand
Global Biologic Therapy Market Ready to Set Superior Growth till 2023 with Major …
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand for biological and targeted drug therapies. Additionally, advancement in technologies for the treatment of chronic diseases and heavy research and development in the biologic therapy industry are likely to enhance the Global Biologic Therapy Market. Factors that are likely to hamper the growth of the market